NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 5BSF designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5BSF_NAD_B_301 | 66% | 20% | 0.118 | 0.923 | 1.77 | 1.62 | 12 | 11 | 0 | 0 | 100% | 1 |
| 5BSF_NAD_I_301 | 64% | 21% | 0.123 | 0.92 | 1.68 | 1.66 | 9 | 12 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_C_301 | 57% | 20% | 0.142 | 0.917 | 1.74 | 1.67 | 11 | 10 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_F_301 | 55% | 18% | 0.141 | 0.908 | 1.97 | 1.59 | 13 | 10 | 2 | 0 | 100% | 1 |
| 5BSF_NAD_A_301 | 52% | 20% | 0.15 | 0.907 | 1.78 | 1.58 | 12 | 11 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_H_301 | 52% | 18% | 0.156 | 0.913 | 1.93 | 1.62 | 12 | 11 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_E_301 | 38% | 18% | 0.163 | 0.866 | 1.83 | 1.67 | 9 | 10 | 2 | 0 | 100% | 1 |
| 5BSF_NAD_J_301 | 36% | 17% | 0.19 | 0.881 | 1.95 | 1.65 | 12 | 12 | 2 | 0 | 100% | 1 |
| 5BSF_NAD_D_301 | 33% | 18% | 0.194 | 0.873 | 1.81 | 1.69 | 9 | 11 | 1 | 0 | 100% | 1 |
| 5BSF_NAD_G_301 | 19% | 19% | 0.249 | 0.847 | 1.85 | 1.61 | 12 | 12 | 1 | 0 | 100% | 1 |
| 2O2Y_NAD_B_1450 | 100% | 23% | 0.024 | 0.995 | 1.79 | 1.4 | 5 | 3 | 1 | 0 | 100% | 1 |
| 3CMC_NAD_R_408 | 100% | 20% | 0.016 | 0.998 | 1.63 | 1.74 | 4 | 9 | 0 | 0 | 100% | 1 |
| 4RQU_NAD_B_403 | 100% | 3% | 0.019 | 0.997 | 3.51 | 2.61 | 13 | 18 | 0 | 0 | 100% | 1 |
| 2BJK_NAD_A_1517 | 100% | 59% | 0.025 | 0.995 | 0.72 | 0.86 | - | 1 | 1 | 0 | 100% | 0.86 |
| 3EC7_NAD_A_400 | 100% | 18% | 0.025 | 0.995 | 1.8 | 1.74 | 5 | 8 | 1 | 0 | 100% | 1 |
